Artia Global Partners »

Guardant Health shares owned by Artia Global Partners

Quarter-by-quarter ownership of Guardant Health (GH) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Guardant Health

Tip: Access up to 7 years of quarterly data

All positions including Guardant Health held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Guardant Health by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.7M 38k 150.03

More positions owned by Artia Global Partners

Abivax Sa Sponsored Ads (ABVX)
Insmed Com Par $.01 (INSM)
Trevi Therapeutics (TRVI)
Brightspring Health Svcs (BTSG)
Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Alkermes SHS (ALKS)
Travere Therapeutics (TVTX)
Astrazeneca Ord (AZN)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Dianthus Therapeutics (DNTH)
Spdr Series Trust St Str Sp Biot (XBI)
Quest Diagnostics Incorporated (DGX)
Ionis Pharmaceuticals (IONS)
Eyepoint Com New (EYPT)

View all positions for Artia Global Partners

Top funds holding Guardant Health

BlackRock
T. Rowe Price Associates
Vanguard Capital Management
FMR
Vanguard Portfolio Management
Invesco
Goldman Sachs Group
Two Sigma Investments
Capital Research and Management Company - Division 3
Deep Track Capital
Franklin Resources
Ameriprise Financial
State Street Corporation
Hanna Zanoni
Geode Capital Management

View all funds holding Guardant Health